MPN-FIT:骨髓增殖性肿瘤监督下运动随机对照预试验
该随机对照预试验纳入55例骨髓增殖性肿瘤患者,按3:2随机分为12周监督下家庭运动组与等待对照组,评估可行性、可接受性及对症状负担、生活质量和炎症标志物的影响。
要点
- 监督下运动在MPN患者中可行且可接受,88%满意、92%愿继续规律运动。
- 受访患者一致推荐该运动方案,并报告症状改善。
核心结论
- 监督下运动在MPN患者中可行、可接受,并显示对炎症/疾病标志物的潜在获益。
研究设计与样本
- 随机对照预试验,55例MPN患者按3:2随机分为12周监督下家庭运动组与等待对照组。
- 运动方案含柔韧性、抗阻和有氧训练,由运动生理学家监督。
- 中位年龄66岁(范围27-86),女性占60%。
主要发现
- 所有可行性指标达标,88%参与者满意,92%有意愿继续规律运动。
- 受访患者报告干预对症状有积极影响,并一致推荐该方案。
临床怎么用
- 可考虑为MPN患者提供由运动生理学家监督的家庭运动方案,作为辅助支持治疗。
局限性
- 原文未报告其他炎症/疾病标志物(CRP、ESR、铁蛋白、血清细胞因子)的组间比较结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myeloproliferative neoplasms (MPN) are associated with a high symptom burden and impaired quality of life (QoL), often unaided by available treatments. Physical activity has demonstrated benefits in other cancers; however, its potential has yet to be explored in MPN. This randomized controlled trial aimed to evaluate the feasibility, acceptability, and efficacy of a supervised exercise program for patients with MPN based on longitudinal assessment of symptom burden, QoL, and clinical/inflammatory markers (C-reactive protein, erythrocyte sedimentation rate, ferritin, lactate dehydrogenase [LDH], and serum cytokines). Patients with MPN (n = 55) were randomized 3:2 to a 12-week home-based exercise intervention (flexibility/resistance/aerobics) supervised by a kinesiologist vs waitlist control. Measures included patient-reported outcome questionnaires, peripheral blood sampling, and postintervention interviews with participants. Forty-seven patients completed the trial (FIT group, n = 26; control group, n = 21). Median age was 66 years (range, 27-86), and 60% were female. All feasibility benchmarks were met, with 88% of participants satisfied and 92% with intent to continue an exercise program on a regular basis. A significant reduction in LDH was observed in FIT patients compared with controls (-14.5 U/L vs +4.0 U/L; P = .03). Patients interviewed described positive effects of the intervention on symptoms and would unanimously recommend the program to others with MPN. In this pilot study, supervised exercise was feasible, acceptable, and showed potential benefits on inflammatory/disease markers.
引用
- Ouellet M, Rizzolo A, Venne C, et al. MPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms. Blood Adv. 2026. PMID: 41499761. doi:10.1182/bloodadvances.2025018682
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。